Navigation Links
AVN944 in Medical Technology

Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial

GERMANTOWN, Md., June 13, 2007 /PRNewswire-FirstCall/ -- Avalon Pharmaceuticals, Inc. , today announced that it is will provide an update on the Phase I clinical trial of AVN944 in hematologic malignancies on Tuesday, June 19, 2007, after the close of the U.S. financial markets. The Company will a...

Avalon Pharmaceuticals to Present at the American Association for Cancer Research 2007 Annual Meeting

...valon Pharmaceuticals, Inc. , today announced that avn944 will be the subject of three poster presentations ...and in vivo experiments that reveal the effects of avn944 on blood vessel formation. The presentation will b...acific Time. Another poster that will discuss avn944 will be presented by the lab of Dr. Beverly Mitche...

Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial

...rly and refractory patients. Interim data indicate avn944 is well tolerated, has dose-dependent pharmacokine...ncouraged by the positive interim results from the avn944 trial," stated Michael Hamilton, M.D., Avalon Phar...tiate multiple Phase II studies." Background: avn944 is an oral small molecule drug that inhibits inosi...
AVN944 in other areas

Avalon Pharmaceuticals Initiates AVN944 Phase I Clinical Trial in ...

We believe that AVN944 has the potential to offer oncologists and cancer patients ... of the safety and tolerability of AVN944 in adult patients with advanced ...

Microsoft Word - 090705_Avalon

Drug Administration (FDA) for their lead candidate, AVN944 for treatment of cancer. ... AVN944 is an inhibitor of the enzyme inosine monophosphate ...

Avalon Updates The AVN944 Phase I Hematologic Malignancies Trial

Avalon Pharmaceuticals, Inc. (Nasdaq: AVRX), today announced that it is will provide an update on the Phase I clinical trial of AVN944 in hematologic malignancies on ...

FOR IMMEDIATE RELEASE Contacts: Avalon Pharmaceuticals, Inc. Noonan ...

AVN944 is an orally bioavailable inhibitor of inosine monophosphate dehydrogenase 1 and 2 ... of sensitivity and resistance to AVN944 ... benefit from AVN944. ...

Avalon Pharmaceuticals Announces the Activation of IND for AVN944 for ...

AVN944 is an oral, small molecule inhibitor of the enzyme inosine monophosphate ... AVN944 was in-licensed by Avalon from Vertex Pharmaceuticals Incorporated ...

Summary of AVALON PHARMACEUTICALS INC - Yahoo! Finance

... therapeutics, and the in-license and development of AVN944. ... AVN944 was in-licensed by us from Vertex in February 2005. Financial Operations Overview ...
Other Tags
(Date:11/26/2014)... 26, 2014 With Thousand Oaks cosmetic ... the prosthodontists at the Anacapa Dental Art Institute in Woodland ... can be daunting for some. , That is why they ... they offer. , “No dentist wants cost to come between ... teeth,” said Dr. Mamaly Reshad, partner in the Anacapa Dental ...
(Date:11/26/2014)... Schaumburg, IL (PRWEB) November 26, 2014 ... of communication management solutions, has been award the ... Telephony Magazine. , This award comes as a ... its capabilities within the Lync ecosystem. Specifically, ISI ... for all modes of Lync communication, including voice, ...
(Date:11/26/2014)... Luis Obispo, CA (PRWEB) November 26, 2014 ... treatment, is offering lower prices in an early celebration ... 26th, Bunion Booties are being offered at the promotional ... Friday promotional pricing is in addition to any automatic ... visit the Bunion Bootie website for complete ...
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, ... Distinguished Preceptorship Award from The American Association ... the advancement of nurse practitioners. The Distinguished Preceptorship ... had made a significant contribution toward increasing the ... of Nurse Practitioners (AANP) is the largest full-service ...
(Date:11/26/2014)... 2014 (HealthDay News) -- Teens prescribed anti-anxiety or ... those drugs than other teens, a new study ... conduct substance abuse assessments on teenagers before prescribing ... "Prescribers and parents don,t realize the abuse potential," ... the University of Michigan School of Nursing. "These ...
Breaking Medicine News(10 mins):Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 2Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 4Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 5Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2
(Date:11/18/2014)... 17, 2014 The Parenteral Drug Association (PDA) today ... will speak and at least seven more will participate in ... Omni Shoreham Hotel in Washington D.C. , ... have significant support from the regulatory agencies in ... in our effort to help advance the use of ...
(Date:11/15/2014)... -- While we may still be a few years away from ... to gain instant access to all that ailed his patients, ... tablets for monitoring and measuring our health are cropping up ... a tad Orwellian to some, but a new survey suggests ... opportunities into their healthcare regime. These are some ...
(Date:11/11/2014)... -- Forensicon, Inc., a Chicago -based digital ... promotion of Yaniv Schiff from Senior Computer ... new role as Director, he will lead company efforts ... and provide leadership within the company,s digital forensics practice ... Schiff joined Forensicon in 2006 and ...
Breaking Biology News(10 mins):FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2
Other Contents